1. Home
  2. OPTX vs QNCX Comparison

OPTX vs QNCX Comparison

Compare OPTX & QNCX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OPTX
  • QNCX
  • Stock Information
  • Founded
  • OPTX 1981
  • QNCX 2012
  • Country
  • OPTX United States
  • QNCX United States
  • Employees
  • OPTX N/A
  • QNCX N/A
  • Industry
  • OPTX Blank Checks
  • QNCX Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • OPTX Finance
  • QNCX Health Care
  • Exchange
  • OPTX Nasdaq
  • QNCX Nasdaq
  • Market Cap
  • OPTX 47.5M
  • QNCX 47.7M
  • IPO Year
  • OPTX N/A
  • QNCX 2019
  • Fundamental
  • Price
  • OPTX $2.00
  • QNCX $1.85
  • Analyst Decision
  • OPTX
  • QNCX Strong Buy
  • Analyst Count
  • OPTX 0
  • QNCX 5
  • Target Price
  • OPTX N/A
  • QNCX $8.00
  • AVG Volume (30 Days)
  • OPTX 124.4K
  • QNCX 237.7K
  • Earning Date
  • OPTX 08-13-2025
  • QNCX 08-12-2025
  • Dividend Yield
  • OPTX N/A
  • QNCX N/A
  • EPS Growth
  • OPTX N/A
  • QNCX N/A
  • EPS
  • OPTX 0.00
  • QNCX N/A
  • Revenue
  • OPTX $29,392,186.00
  • QNCX N/A
  • Revenue This Year
  • OPTX N/A
  • QNCX N/A
  • Revenue Next Year
  • OPTX N/A
  • QNCX N/A
  • P/E Ratio
  • OPTX $1,202.58
  • QNCX N/A
  • Revenue Growth
  • OPTX 4.00
  • QNCX N/A
  • 52 Week Low
  • OPTX $0.85
  • QNCX $0.51
  • 52 Week High
  • OPTX $5.10
  • QNCX $2.45
  • Technical
  • Relative Strength Index (RSI)
  • OPTX 66.55
  • QNCX 62.84
  • Support Level
  • OPTX $1.58
  • QNCX $1.75
  • Resistance Level
  • OPTX $1.93
  • QNCX $1.88
  • Average True Range (ATR)
  • OPTX 0.18
  • QNCX 0.15
  • MACD
  • OPTX 0.09
  • QNCX -0.01
  • Stochastic Oscillator
  • OPTX 59.84
  • QNCX 60.08

About OPTX Syntec Optics Holdings Inc.

Syntec Optics Holdings Inc is vertically integrated from design and component manufacturing for lens system assembly to imaging module integration for system solutions. Making its tools, molding, and nano machining allows close interaction and recut ability, enabling special techniques to hold tolerances to sub-micron levels. It has steadily developed a variety of other complementary manufacturing techniques to provide a wide suite of horizontal capabilities including thin film deposition coatings, glass molding, polymer molding, tool-making, mechanical manufacturing, and nano machining.

About QNCX Quince Therapeutics Inc.

Quince Therapeutics Inc is preclinical stage biopharmaceutical company focused on advancing precision therapeutics for debilitating and rare diseases. The company discovered a broad bone-targeting drug platform designed to precisely deliver small molecules, peptides, or large molecules directly to the site of bone fracture and disease to promote rapid healing with fewer off-target safety concerns compared to non-targeted therapeutics. Company pipeline includes Ataxia-Telangiectasia(EryDex), Duchenne Muscular Dystrophy, New Indications and Program Expansion Potential.

Share on Social Networks: